Skip to main content
Erschienen in: Obesity Surgery 6/2016

02.09.2015 | Original Contributions

Essential Fatty Acid Plasma Profiles Following Gastric Bypass and Adjusted Gastric Banding Bariatric Surgeries

verfasst von: Rebekah Forbes, Danijela Gasevic, Emily M. Watson, Thomas R. Ziegler, Edward Lin, John R. Burgess, Nana Gletsu-Miller

Erschienen in: Obesity Surgery | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Although patients experience hair loss and dry skin which may be attributable to deficiency in essential fatty acids (EFAs), the impact of bariatric surgeries on EFA status is unknown.

Methods

This study aimed to assess plasma phospholipid fatty acid profiles following adjustable gastric banding (AGB), which restricts dietary fat intake, versus Roux-en-Y gastric bypass (RYGB), which also promotes fat malabsorption. Serial measures were obtained before and 1 and 6 months from women undergoing RYGB (N = 13) and AGB (N = 5). Measures included the composition of plasma fatty acids in phospholipids, dietary intake, and body fat mass. Friedman and Mann–Whitney tests were used to assess differences over time and between groups, respectively, p < 0.05.

Results

Dietary intake of fats decreased equally at 1 and 6 months following RYGB and AGB. By 6 months, the RYGB group lost more body fat. There were no remarkable changes in EFA in plasma phospholipids following AGB. However, following RYGB, a transient increase in 20:4N6 (+18 %) and a decrease in 20:3N6 at 1 (−47 %) and 6 months (−47 %) were observed. Similar changes were observed in N3 fatty acids following RYGB, including a transient increase in 22:6N3 (+11 %) and decreases in 20:5N3 (−79 and −67 % at 1 and 6 months, respectively). EFA status improved following surgery in the RYGB group.

Conclusions

We demonstrate alterations in plasma EFA following RYGB. The status of EFA improved, but the decrease in 20:5N3, the precursor for anti-inflammatory eicosanoids, may be a concern.
Literatur
1.
Zurück zum Zitat Holman RT, Johnson SB, Hatch TF. A case of human linolenic acid deficiency involving neurological abnormalities. Am J Clin Nutr. 1982;35:617–23.PubMed Holman RT, Johnson SB, Hatch TF. A case of human linolenic acid deficiency involving neurological abnormalities. Am J Clin Nutr. 1982;35:617–23.PubMed
2.
Zurück zum Zitat Davis BC, Kris-Etherton PM. Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications. Am J Clin Nutr. 2003;78:640–6. Davis BC, Kris-Etherton PM. Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications. Am J Clin Nutr. 2003;78:640–6.
3.
Zurück zum Zitat Nakamura MT, Nara TY. Structure, function, and dietary regulation of delta 6, delta 5, and delta 9 desaturates. Annu Rev Nutr. 2004;24:345–76.CrossRefPubMed Nakamura MT, Nara TY. Structure, function, and dietary regulation of delta 6, delta 5, and delta 9 desaturates. Annu Rev Nutr. 2004;24:345–76.CrossRefPubMed
4.
Zurück zum Zitat Araya J, Rodrigo R, Pettinelli P, et al. Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients. Obesity (Silver Spring). 2010;18:1460–3.CrossRef Araya J, Rodrigo R, Pettinelli P, et al. Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients. Obesity (Silver Spring). 2010;18:1460–3.CrossRef
5.
Zurück zum Zitat Brignardello J, Morales P, Diaz E, et al. Increase of plasma fatty acids without changes in n-6/n-3-PUFA ratio in asymptomatic obese subjects. Arch Latinoam Nutr. 2011;61:149–53.PubMed Brignardello J, Morales P, Diaz E, et al. Increase of plasma fatty acids without changes in n-6/n-3-PUFA ratio in asymptomatic obese subjects. Arch Latinoam Nutr. 2011;61:149–53.PubMed
6.
Zurück zum Zitat Blond JP, Henchiri C, Bezard J. Delta 6 and delta 5 desaturase activities in liver from obese Zucker rats at different ages. Lipids. 1989;24:389–95.CrossRefPubMed Blond JP, Henchiri C, Bezard J. Delta 6 and delta 5 desaturase activities in liver from obese Zucker rats at different ages. Lipids. 1989;24:389–95.CrossRefPubMed
7.
Zurück zum Zitat Rodriguez Y, Giri M, Rottiers R, et al. Obese type 2 diabetics and obese patients have comparable plasma phospholipid fatty acid compositions deviating from that of healthy individuals. Prostaglandins Leukot Essent Fat Acids. 2004;71:303–8.CrossRef Rodriguez Y, Giri M, Rottiers R, et al. Obese type 2 diabetics and obese patients have comparable plasma phospholipid fatty acid compositions deviating from that of healthy individuals. Prostaglandins Leukot Essent Fat Acids. 2004;71:303–8.CrossRef
8.
Zurück zum Zitat Steffen BT, Steffen LM, Tracy R, et al. Obesity modifies the association between plasma phospholipid polyunsaturated fatty acids and markers of inflammation: the Multi-Ethnic Study of Atherosclerosis. Int J Obes. 2012;36:797–804.CrossRef Steffen BT, Steffen LM, Tracy R, et al. Obesity modifies the association between plasma phospholipid polyunsaturated fatty acids and markers of inflammation: the Multi-Ethnic Study of Atherosclerosis. Int J Obes. 2012;36:797–804.CrossRef
9.
Zurück zum Zitat Mueller-Cunningham WM, Quintana R, Kasim-Karakas SE. An ad libitum, very low-fat diet results in weight loss and changes in nutrient intakes in postmenopausal women. J Am Diet Assoc. 2003;103:1600–6.CrossRefPubMed Mueller-Cunningham WM, Quintana R, Kasim-Karakas SE. An ad libitum, very low-fat diet results in weight loss and changes in nutrient intakes in postmenopausal women. J Am Diet Assoc. 2003;103:1600–6.CrossRefPubMed
10.
Zurück zum Zitat Noakes M, Clifton PM. Changes in plasma lipids and other cardiovascular risk factors during 3 energy-restricted diets differing in total fat and fatty acid composition. Am J Clin Nutr. 2000;71:706–12.PubMed Noakes M, Clifton PM. Changes in plasma lipids and other cardiovascular risk factors during 3 energy-restricted diets differing in total fat and fatty acid composition. Am J Clin Nutr. 2000;71:706–12.PubMed
11.
Zurück zum Zitat USDA/HHS. Dietary guidelines for Americans, 2010. U.S. Government Printing Office. Washington, DC: 2010. USDA/HHS. Dietary guidelines for Americans, 2010. U.S. Government Printing Office. Washington, DC: 2010.
12.
Zurück zum Zitat Tang AB, Nishimura KY, Phinney SD. Preferential reduction in adipose tissue a-linolenic acid (18:3w3) during very low calorie dieting despite supplementation with 18:3w3. Lipids. 1993;28:987–93.CrossRefPubMed Tang AB, Nishimura KY, Phinney SD. Preferential reduction in adipose tissue a-linolenic acid (18:3w3) during very low calorie dieting despite supplementation with 18:3w3. Lipids. 1993;28:987–93.CrossRefPubMed
13.
Zurück zum Zitat Cunnane SC, Ross R, Bannister JL, et al. β-oxidation of linoleate in obese men undergoing weight loss. Am J Clin Nutr. 2001;73:709–14.PubMed Cunnane SC, Ross R, Bannister JL, et al. β-oxidation of linoleate in obese men undergoing weight loss. Am J Clin Nutr. 2001;73:709–14.PubMed
14.
Zurück zum Zitat Phinney SD, Davis PG, Johnson SB, et al. Obesity and weight loss alter serum phospholipids in humans. Am J Clin Nutr. 1991;53:831–8.PubMed Phinney SD, Davis PG, Johnson SB, et al. Obesity and weight loss alter serum phospholipids in humans. Am J Clin Nutr. 1991;53:831–8.PubMed
15.
Zurück zum Zitat Holman RT, Adams CE, Nelson RA, et al. Patients with anorexia nervosa demonstrate deficiencies of selected fatty acid, compensatory changes in nonessential fatty acids and decreased fluidity of plasma lipids. J Nutr. 1995;125:901–7.PubMed Holman RT, Adams CE, Nelson RA, et al. Patients with anorexia nervosa demonstrate deficiencies of selected fatty acid, compensatory changes in nonessential fatty acids and decreased fluidity of plasma lipids. J Nutr. 1995;125:901–7.PubMed
16.
Zurück zum Zitat Sweene I, Rosling A, Tengblad S, et al. Essential fatty acid status in teenage girls with eating disorders and weight loss. Acta Paediatr. 2011;100:762–7.CrossRef Sweene I, Rosling A, Tengblad S, et al. Essential fatty acid status in teenage girls with eating disorders and weight loss. Acta Paediatr. 2011;100:762–7.CrossRef
17.
Zurück zum Zitat Christophe A, Vermeulen A. Effects of weight loss on the fatty acid composition of serum lipids in obese women. Ann Nutr Metab. 1992;36:336–42.CrossRefPubMed Christophe A, Vermeulen A. Effects of weight loss on the fatty acid composition of serum lipids in obese women. Ann Nutr Metab. 1992;36:336–42.CrossRefPubMed
18.
Zurück zum Zitat Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009;17:796–802.CrossRef Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009;17:796–802.CrossRef
19.
Zurück zum Zitat Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.CrossRefPubMedPubMedCentral Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56–65.CrossRefPubMed Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56–65.CrossRefPubMed
21.
Zurück zum Zitat Moize V, Andreu A, Rodriguez L, et al. Protein intake and lean tissue mass retention following bariatric surgery. Clin Nutr. 2013;32:550–5.CrossRefPubMed Moize V, Andreu A, Rodriguez L, et al. Protein intake and lean tissue mass retention following bariatric surgery. Clin Nutr. 2013;32:550–5.CrossRefPubMed
22.
Zurück zum Zitat Carlin AM, Rao DS, Yager KM, et al. Effect of gastric bypass surgery on vitamin D nutritional status. Surg Obes Relat Dis. 2006;2:638–42.CrossRefPubMed Carlin AM, Rao DS, Yager KM, et al. Effect of gastric bypass surgery on vitamin D nutritional status. Surg Obes Relat Dis. 2006;2:638–42.CrossRefPubMed
23.
Zurück zum Zitat Ruz M, Carrasco F, Rojas P, et al. Iron absorption and iron status are reduced after Roux-en-Y gastric bypass. Am J Nutr. 2009;90:527–32.CrossRef Ruz M, Carrasco F, Rojas P, et al. Iron absorption and iron status are reduced after Roux-en-Y gastric bypass. Am J Nutr. 2009;90:527–32.CrossRef
25.
Zurück zum Zitat Halawi A, Abiad F, Abbas O. Bariatric surgery and its effects on the skin and skin diseases. Obes Surg. 2013;23:408–13.CrossRefPubMed Halawi A, Abiad F, Abbas O. Bariatric surgery and its effects on the skin and skin diseases. Obes Surg. 2013;23:408–13.CrossRefPubMed
26.
Zurück zum Zitat Coupaye M, Puchaux K, Bogard C, et al. Nutritional consequences of adjustable gastric banding and gastric bypass: a 1-year prospective study. Obes Surg. 2009;19:56–65.CrossRefPubMed Coupaye M, Puchaux K, Bogard C, et al. Nutritional consequences of adjustable gastric banding and gastric bypass: a 1-year prospective study. Obes Surg. 2009;19:56–65.CrossRefPubMed
27.
Zurück zum Zitat Elizondo A, Araya J, Rodrigo R, et al. Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease. Biol Res. 2008;41:59–68.CrossRefPubMed Elizondo A, Araya J, Rodrigo R, et al. Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease. Biol Res. 2008;41:59–68.CrossRefPubMed
28.
Zurück zum Zitat Kumar R, Lieske JC, Collazo-Clavell ML, et al. Fat malabsorption and increased oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery. 2011;149:654–61.CrossRefPubMedPubMedCentral Kumar R, Lieske JC, Collazo-Clavell ML, et al. Fat malabsorption and increased oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery. 2011;149:654–61.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Odstrcil EA, Martinez JG, Santa Ana CA, et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92:704–13.CrossRefPubMed Odstrcil EA, Martinez JG, Santa Ana CA, et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92:704–13.CrossRefPubMed
30.
Zurück zum Zitat Gletsu-Miller N, Hansen JM, Jones DP, et al. Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery. Obesity (Silver Spring). 2009;17:439–46.CrossRef Gletsu-Miller N, Hansen JM, Jones DP, et al. Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery. Obesity (Silver Spring). 2009;17:439–46.CrossRef
31.
Zurück zum Zitat Lin E, Phillips LS, Ziegler TR, et al. Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss. Diabetes. 2007;56:735–42.CrossRefPubMed Lin E, Phillips LS, Ziegler TR, et al. Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss. Diabetes. 2007;56:735–42.CrossRefPubMed
33.
Zurück zum Zitat Lin E, Davis SS, Srinivasan J, et al. Dual mechanism for type-2 diabetes resolution after Roux-en-Y gastric bypass. Am Surg. 2009;75:498–502. discussion -3.PubMedPubMedCentral Lin E, Davis SS, Srinivasan J, et al. Dual mechanism for type-2 diabetes resolution after Roux-en-Y gastric bypass. Am Surg. 2009;75:498–502. discussion -3.PubMedPubMedCentral
34.
Zurück zum Zitat Anonymous. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35 Suppl 1:S64–71. Anonymous. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35 Suppl 1:S64–71.
35.
Zurück zum Zitat Gletsu-Miller N, Kahn HS, Gasevic D, Liang Z, Frediani JK, Torres WE, Ziegler TR, Phillips LS, Lin E. Sagittal abdominal diameter and visceral adiposity: correlates of beta-cell function and dysglycemia in severely obese women. Obes Surg. 2013. Gletsu-Miller N, Kahn HS, Gasevic D, Liang Z, Frediani JK, Torres WE, Ziegler TR, Phillips LS, Lin E. Sagittal abdominal diameter and visceral adiposity: correlates of beta-cell function and dysglycemia in severely obese women. Obes Surg. 2013.
36.
Zurück zum Zitat Liang Y, Roede JR, Dikalov S, et al. Determination of ebselen-sensitive reactive oxygen metabolites (ebROM) in human serum based upon N, N'-diethyl-1,4-phenylenediamine oxidation. Clin Chim Acta. 2012;414:1–6.CrossRefPubMedPubMedCentral Liang Y, Roede JR, Dikalov S, et al. Determination of ebselen-sensitive reactive oxygen metabolites (ebROM) in human serum based upon N, N'-diethyl-1,4-phenylenediamine oxidation. Clin Chim Acta. 2012;414:1–6.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Ohta A, Mayo MC, Kramer N, et al. Rapid analysis of fatty acids in plasma lipids. Lipids. 1990;25:742–7.CrossRefPubMed Ohta A, Mayo MC, Kramer N, et al. Rapid analysis of fatty acids in plasma lipids. Lipids. 1990;25:742–7.CrossRefPubMed
38.
Zurück zum Zitat Antalis CJ, Stevens LJ, Campbell M, et al. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fat Acids. 2006;75:299–308.CrossRef Antalis CJ, Stevens LJ, Campbell M, et al. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fat Acids. 2006;75:299–308.CrossRef
39.
Zurück zum Zitat Holman RT, Smythe L, Johnson S. Effect of sex and age on fatty acid composition of human serum lipids. Am J Clin Nutr. 1979;32:2390–9.PubMed Holman RT, Smythe L, Johnson S. Effect of sex and age on fatty acid composition of human serum lipids. Am J Clin Nutr. 1979;32:2390–9.PubMed
40.
Zurück zum Zitat Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity (Silver Spring). 2009;17 Suppl 1:S1–70. Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity (Silver Spring). 2009;17 Suppl 1:S1–70.
41.
Zurück zum Zitat Garg ML, Thomson AB, Clandinin MT. Interactions of saturated, n-6 and n-3 polyunsaturated fatty acids to modulate arachidonic acid metabolism. J Lipid Res. 1990;31:271–7.PubMed Garg ML, Thomson AB, Clandinin MT. Interactions of saturated, n-6 and n-3 polyunsaturated fatty acids to modulate arachidonic acid metabolism. J Lipid Res. 1990;31:271–7.PubMed
42.
Zurück zum Zitat Olbers T, Bjorkman S, Lindroos A, et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg. 2006;244:715–22.CrossRefPubMedPubMedCentral Olbers T, Bjorkman S, Lindroos A, et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg. 2006;244:715–22.CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Carswell KA, Vincent RP, Belgaumkar AP, Sherwood RA, Amiel SA, Patel AG, le Roux CW. The effect of bariatric surgery on intestinal absorption and transit time. Obes Surg. 2013. Carswell KA, Vincent RP, Belgaumkar AP, Sherwood RA, Amiel SA, Patel AG, le Roux CW. The effect of bariatric surgery on intestinal absorption and transit time. Obes Surg. 2013.
44.
Zurück zum Zitat Rossner S, Walldius G, Bjorvell H. Fatty acid composition in serum lipids and adipose tissue in severe obesity before and after six weeks of weight loss. Int J Obes. 1989;13:603–12.PubMed Rossner S, Walldius G, Bjorvell H. Fatty acid composition in serum lipids and adipose tissue in severe obesity before and after six weeks of weight loss. Int J Obes. 1989;13:603–12.PubMed
45.
Zurück zum Zitat Kunesova M, Phinney S, Hainer V, et al. The responses of serum and adipose fatty acids to a one-year weight reduction regimen in female obese monozygotic twins. Ann N Y Acad Sci. 2002;967:311–23.CrossRefPubMed Kunesova M, Phinney S, Hainer V, et al. The responses of serum and adipose fatty acids to a one-year weight reduction regimen in female obese monozygotic twins. Ann N Y Acad Sci. 2002;967:311–23.CrossRefPubMed
46.
Zurück zum Zitat Tiikkainen M, Bergholm R, Rissanen A, et al. Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women. Am J Clin Nutr. 2004;79:22–30.PubMed Tiikkainen M, Bergholm R, Rissanen A, et al. Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women. Am J Clin Nutr. 2004;79:22–30.PubMed
47.
Zurück zum Zitat Katz DP, Knittle JL. Effects of hypocaloric diet low in essential fatty acids on in vitro human adipose tissue prostaglandin production and essential fatty acid status. Nutrition. 1991;7:256–9.PubMed Katz DP, Knittle JL. Effects of hypocaloric diet low in essential fatty acids on in vitro human adipose tissue prostaglandin production and essential fatty acid status. Nutrition. 1991;7:256–9.PubMed
48.
Zurück zum Zitat Kunesova M, Braunerova R, Hlavaty P, et al. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res. 2006;55:63–72.PubMed Kunesova M, Braunerova R, Hlavaty P, et al. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res. 2006;55:63–72.PubMed
49.
Zurück zum Zitat Hlavaty P, Kunesova M, Gojova M, et al. Change in fatty acid composition of serum lipids in obese females after short-term weight-reducing regimen with the addition of n-3 long chain polyunsaturated fatty acids in comparison to controls. Physiol Res. 2008;57 Suppl 1:S57–65.PubMed Hlavaty P, Kunesova M, Gojova M, et al. Change in fatty acid composition of serum lipids in obese females after short-term weight-reducing regimen with the addition of n-3 long chain polyunsaturated fatty acids in comparison to controls. Physiol Res. 2008;57 Suppl 1:S57–65.PubMed
50.
Zurück zum Zitat Haugaard SB, Vaag A, Hoy CE, et al. Desaturation of skeletal muscle structural and depot lipids in obese individuals during a very-low-calorie diet intervention. Obesity (Silver Spring). 2007;15:117–25.CrossRef Haugaard SB, Vaag A, Hoy CE, et al. Desaturation of skeletal muscle structural and depot lipids in obese individuals during a very-low-calorie diet intervention. Obesity (Silver Spring). 2007;15:117–25.CrossRef
51.
Zurück zum Zitat Phinney SD, Tang AB, Johnson SB, et al. Reduced adipose 18:3w3 with weight loss by very low calorie dieting. Lipids. 1990;25:798–806.CrossRefPubMed Phinney SD, Tang AB, Johnson SB, et al. Reduced adipose 18:3w3 with weight loss by very low calorie dieting. Lipids. 1990;25:798–806.CrossRefPubMed
52.
Zurück zum Zitat Stamatikos AD, Paton CM. Role of stearoyl-CoA desaturase-1 in skeletal muscle function and metabolism. Am J Physiol Endocrinol Metab. 2013;305:E767–75.CrossRefPubMed Stamatikos AD, Paton CM. Role of stearoyl-CoA desaturase-1 in skeletal muscle function and metabolism. Am J Physiol Endocrinol Metab. 2013;305:E767–75.CrossRefPubMed
53.
Zurück zum Zitat Demaria EJ, Winegar DA, Pate VW, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg. 2010;252:559–66. discussion 66-7.PubMed Demaria EJ, Winegar DA, Pate VW, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg. 2010;252:559–66. discussion 66-7.PubMed
54.
Zurück zum Zitat Keidar A, Hershkop KJ, Marko L, et al. Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial. Diabetologia. 2013;56:1914–8.CrossRefPubMed Keidar A, Hershkop KJ, Marko L, et al. Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial. Diabetologia. 2013;56:1914–8.CrossRefPubMed
55.
Zurück zum Zitat Bradley D, Conte C, Mittendorfer B, et al. Gastric bypass and banding equally improve insulin sensitivity and beta cell function. J Clin Invest. 2012;122:4667–74.CrossRefPubMedPubMedCentral Bradley D, Conte C, Mittendorfer B, et al. Gastric bypass and banding equally improve insulin sensitivity and beta cell function. J Clin Invest. 2012;122:4667–74.CrossRefPubMedPubMedCentral
56.
Zurück zum Zitat Ballantyne GH, Farkas D, Laker S, et al. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2006;16:1189–97.CrossRefPubMed Ballantyne GH, Farkas D, Laker S, et al. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2006;16:1189–97.CrossRefPubMed
57.
Zurück zum Zitat Poslusna K, Ruprich J, de Vries JH, et al. Misreporting of energy and micronutrient intake estimated by food records and 24 hour recalls, control and adjustment methods in practice. Br J Nutr. 2009;101 Suppl 2:S73–85.CrossRefPubMed Poslusna K, Ruprich J, de Vries JH, et al. Misreporting of energy and micronutrient intake estimated by food records and 24 hour recalls, control and adjustment methods in practice. Br J Nutr. 2009;101 Suppl 2:S73–85.CrossRefPubMed
Metadaten
Titel
Essential Fatty Acid Plasma Profiles Following Gastric Bypass and Adjusted Gastric Banding Bariatric Surgeries
verfasst von
Rebekah Forbes
Danijela Gasevic
Emily M. Watson
Thomas R. Ziegler
Edward Lin
John R. Burgess
Nana Gletsu-Miller
Publikationsdatum
02.09.2015
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 6/2016
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-015-1876-3

Weitere Artikel der Ausgabe 6/2016

Obesity Surgery 6/2016 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.